|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
By Industry | By Industry Segment | By Services and Suppliers
| By Location
| By Hotbed |
Profile Search
|
..
Solutia, Inc.
575 Maryville Center Drive
P.O. Box 66760
St. Louis
Missouri
63166-6760
U.S.A.
Phone:
314-674-1000
Fax:
|
Solutia Pharmaceutical Services Division
Seamless Development from Bench to Market
Solutia has acquired two leading Swiss companies, CarboGen and Amcis, to provide the Science, Speed and Quality demanded in developing new ethical drugs. Pharmaceutical and biotechnology companies can now globally outsource with Solutia for separate drug development services, or for an entire, seamless process from research through small scale commercial manufacturing.
CarboGen specializes in providing research-based pharmaceutical companies with process research and development, analytical development and the rapid synthesis of API supplies prepared to cGMP. Together, CarboGen's two facilities employ over 200 chemists, of which around 100 have PhDs. CarboGen is a reliable and confidential partner with project management and technology transfer expertise of the highest standards.
AMCIS specializes in contract process development and cGMP manufacturing of key intermediates and bulk APIs for the research based pharmaceutical industry worldwide. With their history, chemical background and scale-up expertise, the 100 staff at Amcis are experts in a broad range of modern organic chemistry, providing reliable and economical processes for commercial scale manufacturing.
With the complementary skills and common systems of CarboGen and Amcis we are able to bring projects to a conclusion in the most efficient manner. Underpinned by our state-of-the-art project management techniques, we are able to drive the synergies within these two businesses. This provides an effective solution which takes time out of the overall project timeline and so allows our customers to achieve their goal of getting more products through the Development Pipeline faster then ever.
Contact:
Frank Kumli, Marketing Manager
Phone: +41 61 935 53 53
Fax: : +41 61 935 53 88
E-mail: Frank.Kumli@solutia.com
Last Updated: 08-19-04
Email:
Ownership:
Public
Web Site:
Solutia, Inc.
Employees:
Symbol: SOI
|
|
|
Company News |
Solutia, Inc. (SOI) Announces Sale of Perkalink® Business and Select Primary Accelerators Assets
11/8/2010 10:44:00 AM
More...
|
Solutia, Inc. (SOI) Opens New Photovoltaic Laboratory
10/12/2010 9:20:45 AM
More...
|
Solutia, Inc. (SOI) to Present at Credit Suisse Future Energy Conference
6/2/2010 10:31:26 AM
More...
|
Solutia, Inc. (SOI) Reports Fourth Quarter and Full Year 2009 Results
1/28/2010 8:40:17 AM
More...
|
Solutia, Inc. (SOI) Reaches Agreement To Sell Pharmaceutical Services Business To Dishman Pharmaceuticals and Chemicals Ltd For $74.5 Million
5/24/2006 3:04:45 PM
More...
|
Monsanto Company (MON) Welcomes Filing Of Solutia, Inc. (SOI) Reorganization Plan
2/14/2006 10:23:08 AM
More...
|
Solutia, Inc. (SOI) Announces Price Increase In Adipic Acid
10/19/2005 5:12:17 PM
More...
|
Solutia, Inc.'s (SOI) U.S. Labor Unions Approve New Collective Bargaining Agreements
10/19/2005 5:12:12 PM
More...
|
Solutia, Inc. (SOI) Enters Field Of Anti-Cancer Drug Conjugates
10/19/2005 5:11:35 PM
More...
|
Solutia, Inc. (SOI) May Sell Off Pharma Business
10/19/2005 5:11:19 PM
More...
|
|
|
|
 |
|
|
|
|
|
|
|
|